These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 12642727

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS, Cerfolio RJ.
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The heart or a tumor? Lung cancer in the lower left thorax can mimic myocardial FDG uptake on PET imaging.
    Ponzo F, Zhuang H, Woodfield C, Alavi A.
    Clin Nucl Med; 2003 Feb; 28(2):146-9. PubMed ID: 12544141
    [No Abstract] [Full Text] [Related]

  • 6. Dual-phase F-18 FDG PET cannot increase the diagnostic accuracy to differentiate solitary pulmonary nodules.
    Chen YK, Shen YY, Kao CH.
    Clin Nucl Med; 2004 Apr; 29(4):281-3. PubMed ID: 15096984
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
    Daniels CE, Lowe VJ, Aubry MC, Allen MS, Jett JR.
    Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Lee ST, Berlangieri SU, Poon AM, Mitchell P, Pathmaraj K, Tabone K, Byrne AJ, O'Keefe GJ, Knight SR, Clarke CP, Scott AM.
    Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. False-positive FDG positron emission tomography in pulmonary amyloidosis.
    Ollenberger GP, Knight S, Tauro AJ.
    Clin Nucl Med; 2004 Oct; 29(10):657-8. PubMed ID: 15365447
    [No Abstract] [Full Text] [Related]

  • 15. [Positron-emission tomography in the evaluation of lung cancer].
    Torres García AJ, Carreras Delgado JL.
    Arch Bronconeumol; 1997 Dec; 33(11):553-5. PubMed ID: 9508470
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Localized form of bronchioloalveolar carcinoma: FDG PET findings.
    Kim BT, Kim Y, Lee KS, Yoon SB, Cheon EM, Kwon OJ, Rhee CH, Han J, Shin MH.
    AJR Am J Roentgenol; 1998 Apr; 170(4):935-9. PubMed ID: 9530038
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
    Präuer HW, Weber WA, Römer W, Treumann T, Ziegler SI, Schwaiger M.
    Br J Surg; 1998 Nov; 85(11):1506-11. PubMed ID: 9823912
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.